Taxotere is active in small cell lung cancer (SCLC) a phase II trial of the eortc early clinical trials group (ECTG)

J F Smyth, Stuart Kaye(University of Wollongong), I E Smith, C. Sessa(Vita-Salute San Raffaele University), A. Bowman
European Journal of Cancer
January 1, 1993
Cited by 4


Related Papers